Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor.

Ahsan, Tamim; Sajib, Abu Ashfaqur

Ahsan, Tamim; Sajib, Abu Ashfaqur.

Afiliação

Ahsan T; Department of Genetic Engineering & Biotechnology, Bangabandhu Sheikh Mujibur Rahman Maritime University, Dhaka, 1216, Bangladesh.
Sajib AA; Department of Genetic Engineering & Biotechnology, University of Dhaka, Dhaka, 1000, Bangladesh.

Biochem Biophys Rep ; 26: 100982, 2021 Jul.

Article em En | MEDLINE | ID: mdl-33817352

Palavras-chave

ACE1; ACE2; COVID-19; Drug repurposing; Host-virus interaction; SARS-CoV-2; Spike protein

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006196
https://dx.doi.org/10.1016/j.bbrep.2021.100982

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bangladesh

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006196
https://dx.doi.org/10.1016/j.bbrep.2021.100982

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bangladesh